Chordate Medical Holding AB Logo

Chordate Medical Holding AB

Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free neuromodulation treatment technology. The product is designed for the treatment of chronic migraine and chronic rhinitis, offering a clinically proven alternative to conventional medication with minimal side effects. The company markets its treatment in selected markets within the EU and the Middle East. Its business strategy is focused on building value through clinical validation, an extensive patent portfolio, and commercial success stories to attract prospective buyers for a future exit.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordate Medical Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

Company Country Ticker View
Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland AME
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America DRTS
ANGIODYNAMICS INC Logo
Develops minimally invasive medical devices for vascular and oncology applications.
United States of America ANGO
Apyx Medical Corp Logo
Develops helium plasma energy devices for cosmetic and surgical markets.
United States of America APYX
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea 450950
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America AMIX
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America BDMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.